Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances

5 years ago

Chromone as a Privileged Scaffold in Drug Discovery: Recent Advances

Alexandra Gaspar, Nuno Milhazes, Joana Reis, Fernanda Borges

The use of privileged structures in drug discovery has proven to be an effective strategy, allowing the generation of innovative hits/leads and successful optimization processes. Chromone is recognized as a privileged structure and a useful template for the design of novel compounds with potential pharmacological interest, particularly in the field of neurodegenerative, inflammatory, and infectious diseases as well as diabetes and cancer. This perspective provides the reader with an update of an earlier article entitled “Chromone: A Valid Scaffold in Medicinal Chemistry” ( Chem. Rev. 2014, 114, 4960−4992) and is mainly focused on chromones of biological interest, including those isolated from natural sources. Moreover, as drug repurposing is becoming an attractive drug discovery approach, recent repurposing studies of chromone-based drugs are also reported.

Publisher URL: http://dx.doi.org/10.1021/acs.jmedchem.6b01720

DOI: 10.1021/acs.jmedchem.6b01720